Registration number: 04144959

Industrial Scientific UK Limited

Contents

Company Information	1
Statement of Directors' Responsibilities	2
Balance Sheet	3
Notes to the Financial Statements	4 to 8

Industrial Scientific UK Limited

Company Information

Directors

Industrial Scientific France SAS F P Burke I Genesio G Boorman

Registered office

Suite 1 Bollin House Bollin Walk Wimslow Cheshire SK9 1DP

Bankers

HSBC Bank plc RMS Dept Level 2 Park Street London SE1 9DZ

Auditors

HGA Accountants & Financial Consultants Limited Chartered Accountants & Registered AuditorsSuite 2a 7th Floor City Reach 5 Greenwich View Place London E14 9NN

Industrial Scientific UK Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

•	select suitable accounting policies and apply them consistently;

•	make judgements and accounting estimates that are reasonable and prudent;

•	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Industrial Scientific UK Limited

(Registration number: 04144959)
Balance Sheet as at 31 December 2024

	Note	2024 £	2023 £
Fixed assets
Tangible assets	4	20,388	31,465
Current assets
Stocks	5	77,090	172,854
Debtors	6	995,064	899,514
Cash at bank and in hand		1,802,602	1,843,594
		2,874,756	2,915,962
Creditors: Amounts falling due within one year	7	(237,267)	(335,372)
Net current assets		2,637,489	2,580,590
Net assets		2,657,877	2,612,055
Capital and reserves
Called up share capital		4,000,000	4,000,000
Retained earnings		(1,342,123)	(1,387,945)
Shareholders' funds		2,657,877	2,612,055

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 19 December 2025 and signed on its behalf by:
 

......................................... I Genesio Director

Industrial Scientific UK Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Suite 1 Bollin House
Bollin Walk
Wimslow
Cheshire
SK9 1DP

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentational currency is pound sterling (£). All figures are rounded to the nearest whole pound.

Audit report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 23 December 2025 was Faustino Franco, who signed for and on behalf of HGA Accountants & Financial Consultants Limited.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the Company's activities.

Industrial Scientific UK Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Tax

The tax expense for the period comprises deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Plant and machinery	25% straight line basis
Fixtures and fittings	15% straight line basis
Office equipment	33% straight line basis
Operating lease assets	On a straight line basis over the term of the underlying lease

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as an employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Industrial Scientific UK Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Financial instruments

Classification
Basic financial assets, including trade and other debtors, cash and bank balances, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

Basic financial liabilities, including trade and other trade creditors, bank and other loans, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Such liabilities are subsequently carried at amortised cost using the effective interest method.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is an enforceable right to set off the recognised amounts and there is an intention to settle the liability simultaneously.

 Recognition and measurement
At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit and loss.

 Impairment
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised in the profit or loss.

Financial assets are derecognised when a) the contractual rights to the cash flows from the asset expire or are settled, or b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

3	Staff numbers

The average number of persons employed by the company (excluding directors) during the year, was 5 (2023 - 8).

Industrial Scientific UK Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

4	Tangible assets

	Operating lease assets  £	Total £
Cost or valuation
At 1 January 2024	316,259	316,259
Additions	537	537
Disposals	(30,800)	(30,800)
At 31 December 2024	285,996	285,996
Depreciation
At 1 January 2024	284,794	284,794
Charge for the year	11,614	11,614
Eliminated on disposal	(30,800)	(30,800)
At 31 December 2024	265,608	265,608
Carrying amount
At 31 December 2024	20,388	20,388
At 31 December 2023	31,465	31,465

5

Stocks

	2024 £	2023 £
Other inventories	77,090	172,854

Industrial Scientific UK Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

6

Debtors

	Note	2024 £	2023 £
Trade debtors		210,935	344,872
Amounts owed by group undertakings and undertakings in which the company has a participating interest	8	200,587	777
Prepayments		43,292	33,211
Other debtors		540,250	520,654
		995,064	899,514

7

Creditors

	Note	2024 £	2023 £
Due within one year
Bank loans and overdrafts		-	14,806
Trade creditors		46,259	82,883
Amounts owed to group undertakings and undertakings in which the company has a participating interest	8	4,106	155,472
Taxation and social security		51,081	10,154
Other creditors		135,821	72,057
		237,267	335,372

8	Related party transactions

The company has taken advantage of the exemption allowed under FRS 102 paragraph 33.1A not to disclose details of transactions with entities that are wholly owned members of a group.

9	Parent and ultimate parent undertaking

The company's immediate parent is Industrial Scientific France SAS, incorporated in France.

 The ultimate controlling party is Fortive Corporation, a company resident in the USA. Copies of its financial statements are available to the public on its website (www.fortive.com).

10	Going Concern

The company has the financial support of a parent company, Industrial Scientific Corporation for the foreseeable future. Accordingly, the directors continue to adopt the going concern basis in preparing the annual report and accounts.